// App-Quantinova.ai

P087 : Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Impact of Ulcerative Colitis Symptoms on Daily Life

Researchers

Presenter

  • Dubinsky, M.C

Principal Investigators

  • Schreiber, S

  • Potts Bleakman, A

  • Kayhan, C

  • Ellis, H

  • Hunter Gibble, T

  • Flynn, E

  • Suldecki, G

  • Travis, S

Medical Centers

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • University Hospital Schleswig-Holstein, Clinic of Internal Medicine I, Kiel, Germany

  • Eli Lilly and Company, Eli Lilly and Company, Indianapolis, IN

  • Adelphi Real World, Bollington, United Kingdom

  • University of Oxford, Translational Gastroenterology, Oxford, United Kingdom

Locations

  • United States

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved